MedTrace Logo

Clinical Trials

NCT05987241 | RECRUITING | PHASE2/PHASE3
992 participants

Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-11
Start Date:
2024-02-02
Completion:
2030-09-02
Conditions
  • Muscle Invasive Bladder Urothelial Carcinoma
  • Muscle Invasive Renal Pelvis Urothelial Carcinoma
  • Muscle Invasive Ureter Urothelial Carcinoma
  • Muscle Invasive Urethral Urothelial Carcinoma
  • Stage II Bladder Urothelial Carcinoma AJCC v6 and v7
  • Stage III Bladder Urothelial Carcinoma AJCC v6 and v7
  • Stage IV Bladder Urothelial Carcinoma AJCC v7
Interventions
  • PROCEDURE
  • OTHER
  • BIOLOGICAL
No Results Yet
NCT05872737 | COMPLETED | NA
154 participants

FAB Programme for Parents of Children With NDD

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-11
Start Date:
2023-06-05
Completion:
2025-04-16
Conditions
  • Autism Spectrum Disorder
  • Attention Deficit Hyperactivity Disorder
  • Neurodevelopmental Disorders
  • Intellectual Disability
  • Specific Learning Disorder
  • Communication Disorders
  • Motor Disorders
Interventions
  • BEHAVIORAL
No Results Yet
NCT05858164 | COMPLETED | PHASE1
45 participants

A First-in-human Study to Learn How Safe the Study Treatment BAY2862789 is, to Find the Best Dose, How it Affects the Body, What Maximum Amount Can be Given, How it Moves Into, Through and Out of the Body, and How it Acts on Different Tumors in Participants With Advanced Solid Tumors

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-11
Start Date:
2023-08-07
Completion:
2025-09-26
Conditions
  • Advanced Solid Tumors
  • Non-small Cell Lung Cancer
Interventions
  • DRUG
No Results Yet
NCT05857332 | RECRUITING | PHASE1
60 participants

SG1906 for CLDN18.2-Positive Solid Tumors

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-11
Start Date:
2023-05-30
Completion:
2027-02-28
Conditions
  • Locally Advanced Unresectable or Metastatic Solid Tumors
Interventions
  • DRUG
No Results Yet
NCT05837949 | ACTIVE_NOT_RECRUITING | NA
100 participants

Multiple Sclerosis Falls Insight Track

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-11
Start Date:
2023-04-12
Completion:
2026-09-01
Conditions
  • Multiple Sclerosis
Interventions
  • BEHAVIORAL
No Results Yet
NCT05706129 | RECRUITING | PHASE1/PHASE2
270 participants

A Study to Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerability, and Efficacy of [177Lu]Lu-DPI-4452 in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-11
Start Date:
2023-03-14
Completion:
2027-06-30
Conditions
  • Clear Cell Renal Cell Cancer (ccRCC)
  • Pancreatic Ductal Adenocarcinoma (PDAC)
  • Colorectal Cancer (CRC)
  • Urothelial Carcinoma (UC)
  • Indeterminate Renal Mass (IDRM)
  • Muscle Invasive Bladder Cancer (MIBC)
  • Head and Neck Cancer (H&N)
  • Triple Negative Breast Cancer (TNBC)
  • Squamous Non-Small Cell Lung Cancer (NSCLC)
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page